TCF7L2 and melanoma: Keeping in mind that phenotype switching in melanoma cells entails the exclusive expression of β-catenin cofactors LEF1 or TCF7L2 [60], we interrogated whether SPARC can be integrated into this process, either in the presence or absence of PRRX1 expression.